Furthermore, our study demonstrated a significant increase in tumor growth upon NPY treatment, along with an increased brain metastatic burden in a low BMI setting, indicating its distinct role in lung cancer progression beyond regulating feeding behavior and energy homeostasis127,128. The gene discussed is NPY; the disease is neoplasm.